Is ect safe in patients with cerebrovascular disease?

✍ Scribed by Patricia Anna Blackburn; Peter Decalmer

• Publisher: John Wiley and Sons
• Year: 1994
• Tongue: English
• Weight: 435 KB
• Volume: 9
• Category: Article
• ISSN: 0885-6230
• DOI: 10.1002/gps.930090911

✦ Synopsis

Abstract

A 70‐year‐old man with a history of peripheral vascular disease was treated initially with antidepressants, then bilateral electroconvulsive therapy (ECT) for a depressive illness. Apart from an episode of delirium following ECT he recovered fully. Four years later he relapsed. Low‐dose antidepressants caused disorientation and oversedation, as did ECT. Shortly afterwards he developed a multi‐infarct state with Parkinsonian symptoms, transient schaemic attacks (TIAs) and cerebrovascular attacks (CVAs). His cognitive deficits implicated pathology in the frontal and subcortical areas of the brain. Postmortem examination confirmed widespread atherosclerotic disease, also cerebrovascular disease. The haemodynamic and cerebral effects of ECT are condidered in the context of vascular disease. It is postulated that ECT given to such patients might cause permanent impairment of cognitive function through ischaemia of an already compromised cerebral circulation. Suggestions are outlined regarding a policy for a more comprehensive assessment of patients with atherosclerotic disease. Deficiencies of ECT procedures are highlighted.